Preventive Nutrition and Food Science

  • 제7권2호
  • /
  • Pages.168-173
  • /
  • 2002
  • /
  • 2287-1098(pISSN)
  • /
  • 2287-8602(eISSN)
한국식품영양과학회 (The Korean Society of Food Science and Nutrition)
권호 표지
DOI QR코드

DOI QR Code

Ability of Lactobacillus GR-1 and RC-14 to Stimulate Host Defences and Reduce Gut Translocation and Infectivity of Salmonella typhimurium

  • Reid, Gregor (Lawson Health Research Institute, and Departments of Microbiology and Immunology, and Surgery, The University of Western Ontario, London, Ontario Canada) ;
  • Charbonneau, Duane (Procter & Gamble Healthcare Research Centre, Mason, Ohio) ;
  • Erb, Julie (Procter & Gamble Healthcare Research Centre, Mason, Ohio, USA) ;
  • Poehner, Russ (Procter & Gamble Healthcare Research Centre, Mason, Ohio, USA) ;
  • Gonzalez, Silvia (Centro de Referencias para Lactobacilos (CERELA), Tucuman, Agrentina) ;
  • Gardiner, Gillian (Lawson Health Research Institute) ;
  • Bruce, Andrew W. (Lawson Health Research Institute)
  • 발행 : 2002.06.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Gastrointestinal infections kill over two million people each year, and pathogen contamination of livestock causes many cases of food poisoning. Two candidate intestinal probiotic strains, L. rhamnosus GR-1 and L. fermentum RC-14 were found to inhibit the growth of Salmonella typhi, Shigella dysenteriae, E. coli O157:H7, Listeria monocytogenes, L. innocua, Enterococcus faecalis, and Bacteroides fragilis. In a series of mouse experiments, L. rhamosus GR-1 and L rhamnosus GG protected against S. typhimurium infection and translocation to the liver and spleen, reduced mortality and induced intestinal phagocytic and immunoglobulin responses. In a second series of experiments, the combination of L. rhamnosus GR-1 and L. fermentum RC-14 was superior to L. rhamnosus GG and placebo in protecting the mice from the lethal effect of salmonella. In summary, the use of combinations of probiotic lactobacilli as dietary supplements or foods could be considered for people at high risk of salmonella intestinal infection. Given the post-infection complications that can arise, such natural methods warrant further exploration especially given the increasing problem of antibiotic resistance and the lack of alternative measures available to many developing countries.

키워드

참고문헌

  1. Rabsch W, Tschape H, Baumler AJ. 2001. Salmonella typhimurium strains resistant to multiple antibiotics have emerged and spread within populations of food animals. Non-typhoidal salmonellosis: emerging problems. Microbes Infect 3: 237-247 https://doi.org/10.1016/S1286-4579(01)01375-2
  2. Ribeiro H Jr. 2000. Diarrheal disease in a developing nation. Am J Gastroenterol 95: S14-15 https://doi.org/10.1016/S0002-9270(99)00810-2
  3. Villar RG, Macek MD, Simons S, Hayes PS, Goldoft MJ, Lewis JH, Rowan LL, Hursh D, Patnode M, Mead PS. 1999. Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA 281: 1811-1816 https://doi.org/10.1001/jama.281.19.1811
  4. Guerrant RL, Lima AA, Barboza M, Young S, Silva T, Barrett L, Bao Y, Fox J, Moore S. 1999. Mechanisms and impact of enteric infections. Adv Exp Med Biol 473: 103-112 https://doi.org/10.1007/978-1-4615-4143-1_8
  5. FAO/WHO. 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report, http://www.fao.org/es/ESN/Probio/probio.htm
  6. De Roos NM, Katan MB. 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 71: 405-411
  7. Saxelin M. 1997. Lactobacillus GG-A human probiotic strain with thorough clinical documentation. Food Rev Int 13: 293-313 https://doi.org/10.1080/87559129709541107
  8. Guandalini S, Pensabene L, Zikri MA. 2000. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 54-60 https://doi.org/10.1097/00005176-200001000-00018
  9. Oberhelman RA, Gilman RH, Sheen P, Taylor DN, Black RE, Cabrera L, Lescano AG, Meza R, Madico G. 1999. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 134: 1-2 https://doi.org/10.1016/S0022-3476(99)70360-4
  10. Yasui H, Shida K, Matsuzaki T, Yokokura T. 1999 Immunomodulatory function of lactic acid bacteria. Antonie van Leeuwenhoek 76: 383-389 https://doi.org/10.1023/A:1002041616085
  11. Reid G, Bruce AW. 2001. Selection of Lactobacillus strains for urogenital probiotic applications. J Infect Dis 183: S77-80 https://doi.org/10.1086/318841
  12. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. 2001. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 30: 49-52 https://doi.org/10.1111/j.1574-695X.2001.tb01549.x
  13. Gardiner G, Heinemann C, Madrenas J, Bruce AW, Beuerman D, Baroja L, Reid G. 2002. Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications. Int Dairy J 12: 191-196 https://doi.org/10.1016/S0958-6946(01)00138-8
  14. Gardiner G, Heinemann C, Beuerman D, Bruce AW, Reid G. 2002. Persistence of Lactobacillus fermentum RC-14 and L. rhamnosus GR-1, but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA (RAPD). Clin Diag Lab Immunol 9: 92-96
  15. McGroarty JA, Reid G. 1988. Detection of a lactobacillus substance which inhibits Escherichia coli. Can J Microbiol 34: 974-978 https://doi.org/10.1139/m88-171
  16. Perdigon G, Alvarez S, Pesce de Ruiz Holgado A. 1991. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J Dairy Res 58: 485- 496 https://doi.org/10.1017/S0022029900030090
  17. Perdigon G, Rachid M, De Budeguer MV, Valdez JC. 1994. Effect of yogurt feeding on the small and large intestine associated lymphoid cells in mice. J Dairy Res 61: 553-562 https://doi.org/10.1017/S002202990002848X
  18. McCracken VJ, Gaskins HR. 1999. Probiotics and the immune system. In Probiotics: a clinical review. Horizon Scientific Press, Wymondham, UK. p 85-111
  19. Henriksson A, Conway PL. 2001. Isolation of human faecal bifidobacteria which reduce signs of Salmonella infection when orogastrically dosed to mice. J Appl Microbiol 90: 223-228 https://doi.org/10.1046/j.1365-2672.2001.01238.x
  20. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. 1995. Lactobacillus GG promotes recovery from acute non bloody diarrhea in Pakistan. Ped Infect Dis J 14: 107- 111 https://doi.org/10.1097/00006454-199502000-00005
  21. Shanahan F. 2000. Immunology. Therapeutic manipulation of gut flora. Science 289: 1311-1312 https://doi.org/10.1126/science.289.5483.1311
  22. Heinemann C, Van Hylckama Vlieg JET, Janssen DB, Busscher HJ, van der Mei HC, Reid G. 2000. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 inhibiting Enterococcus faecalis 1131 adhesion. FEMS Microbiol Letts 190: 177-180 https://doi.org/10.1111/j.1574-6968.2000.tb09282.x
  23. Chan RCY, Reid G, Irvin RT, Bruce AW, Costerton JW. 1985. Competitive exclusion of uropathogens from uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 47: 84-89
  24. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276: G941-950
  25. Thomson GT, Chiu B, De Rubeis D, Falk J, Inman RD. 1992. Immunoepidemiology of post-Salmonella reactive arthritis in a cohort of women. Clin Immunol Immunopathol 64: 227-232 https://doi.org/10.1016/0090-1229(92)90204-2
  26. McKendrick MW. 1996. Post Salmonella irritable bowel syndrome-5 year review. J Infect 32: 170-171

피인용 문헌

  1. Probiotics for Mother and Child vol.38, pp.Supplement 2, 2004, https://doi.org/10.1097/01.mcg.0000128923.68543.7f
  2. The development of probiotics for women’s health vol.63, pp.4, 2017, https://doi.org/10.1139/cjm-2016-0733
  3. Growth and survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in yogurt for use as a functional food vol.10, pp.2, 2009, https://doi.org/10.1016/j.ifset.2008.10.007
  4. Efficacy of High-dose Lactobacillus rhamnosus GG in Controlling Acute Watery Diarrhea in Indian Children vol.43, pp.3, 2009, https://doi.org/10.1097/MCG.0b013e31815a5780
  5. Probiotics for the Developing World vol.39, pp.6, 2005, https://doi.org/10.1097/01.mcg.0000165648.32371.38
  6. Probiotics in Paediatric Disorders vol.20, pp.1, 2006, https://doi.org/10.2165/00124363-200620010-00004
  7. Oral use ofLactobacillus rhamnosusGR-1 andL. fermentumRC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women vol.35, pp.2, 2003, https://doi.org/10.1016/S0928-8244(02)00465-0
  8. vol.62, pp.2, 2007, https://doi.org/10.3412/jsb.62.271
  9. Effect of Micronutrient and Probiotic Fortified Yogurt on Immune-Function of Anti-Retroviral Therapy Naive HIV Patients   vol.3, pp.12, 2011, https://doi.org/10.3390/nu3100897
  10. The Potential Role Of Probiotics In Pediatric Urology 2002, https://doi.org/10.1097/00005392-200210010-00071
  11. The Potential Role Of Probiotics In Pediatric Urology vol.168, pp.4, 2002, https://doi.org/10.1016/S0022-5347(05)64507-7
  12. Development of probiotic vegetable juice usingLactobacillus RhamnosusGR-1 vol.50, pp.5, 2019, https://doi.org/10.1108/nfs-06-2019-0192